Financhill
Back

Akero Therapeutics Vs. Bright Minds Biosciences Industry Stock Comparison

Sell
34

AKRO
Akero Therapeutics

Last Price:
$28.21
Seasonality Move:
-11.78%
Sell
45

DRUG
Bright Minds Biosciences

Last Price:
$39.35
Seasonality Move:
-32.13%
Sell
34
Akero Therapeutics (AKRO) is a Sell

Is Akero Therapeutics a Buy, Sell or Hold?

  • The current Akero Therapeutics [AKRO] share price is $28.24. The Score for AKRO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Bright Minds Biosciences (DRUG) is a Sell

Is Bright Minds Biosciences a Buy, Sell or Hold?

  • The current Bright Minds Biosciences [DRUG] share price is $39.85. The Score for DRUG is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • DRUG is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKRO Stock Price Chart

What is Akero Therapeutics's stock price today?

  • The Akero Therapeutics share price today is $28.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight selling pressure.

DRUG Stock Price Chart

What is Bright Minds Biosciences's stock price today?

  • The Bright Minds Biosciences share price today is $39.85
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DRUG is experiencing slight buying pressure.

AKRO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 42.96 Sell
Chaikin Money Flow: -88048 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (28.28 - 31.02) Sell
Bollinger Bands (100): (26.59 - 31.33) Sell

DRUG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.04 Buy
Relative Strength Index (14 RSI): 51.96 Buy
Chaikin Money Flow: 6916 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.23 - 42.31) Buy
Bollinger Bands (100): (3.23 - 44.21) Buy

AKRO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.27 Sell
20-day SMA: 29.17 Sell
50-day SMA: 30.5 Sell
200-day SMA: 25.9 Buy
8-day EMA: 28.35 Sell
20-day EMA: 29.07 Sell
50-day EMA: 29.58 Sell
200-day EMA: 27.86 Buy

DRUG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 38.78 Buy
20-day SMA: 38.81 Buy
50-day SMA: 41.79 Sell
200-day SMA: 12.42 Buy
8-day EMA: 39 Buy
20-day EMA: 39.09 Buy
50-day EMA: 36.04 Buy
200-day EMA: 18.43 Buy

Akero Therapeutics Earnings Growth & AKRO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.90 per share, and an increase next year of $0.20 per share.

Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Akero Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Bright Minds Biosciences Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):